Raras
Buscar doenças, sintomas, genes...
Doença renal túbulo-intersticial autossômica dominante
ORPHA:34149CID-10 · Q61.5CID-11 · GB82DOENÇA RARA

Uma doença renal genética que causa a perda progressiva da função dos rins, provocada por mutações (alterações) nos genes que produzem as proteínas uromodulina (UMOD), fator nuclear de hepatócitos-1β (HNF1B), renina (REN) ou mucina-1 (MUC1).

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Uma doença renal genética que causa a perda progressiva da função dos rins, provocada por mutações (alterações) nos genes que produzem as proteínas uromodulina (UMOD), fator nuclear de hepatócitos-1β (HNF1B), renina (REN) ou mucina-1 (MUC1).

Publicações científicas
185 artigos
Último publicado: 2026 Apr 10
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q61.5
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫘
Rins
26 sintomas
🩸
Sangue
2 sintomas
👂
Ouvidos
1 sintomas
🧠
Neurológico
1 sintomas
📏
Crescimento
1 sintomas
🦴
Ossos e articulações
1 sintomas

+ 9 sintomas em outras categorias

Características mais comuns

Depuração renal de ácido úrico prejudicada
Doença renal crônica estágio 5
Atrofia cortical renal
Hipoplasia renal
Fibrose túbulo-intersticial
Nefrite túbulo-intersticial
41sintomas
Sem dados (41)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 41 características clínicas mais associadas, ordenadas por frequência.

Depuração renal de ácido úrico prejudicadaImpaired renal uric acid clearance
Doença renal crônica estágio 5Stage 5 chronic kidney disease
Atrofia cortical renalRenal cortical atrophy
Hipoplasia renalRenal hypoplasia
Fibrose túbulo-intersticialTubulointerstitial fibrosis

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico185PubMed
Últimos 10 anos173publicações
Pico202525 papers
Linha do tempo
2026Hoje · 2026📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

2 genes identificados com associação a esta condição.

Autosomal dominant
MUC1Mucin-1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

The alpha subunit has cell adhesive properties. Can act both as an adhesion and an anti-adhesion protein. May provide a protective layer on epithelial cells against bacterial and enzyme attack The beta subunit contains a C-terminal domain which is involved in cell signaling, through phosphorylations and protein-protein interactions. Modulates signaling in ERK, SRC and NF-kappa-B pathways. In activated T-cells, influences directly or indirectly the Ras/MAPK pathway. Promotes tumor progression. Re

LOCALIZAÇÃO

Apical cell membraneSecretedCell membraneCytoplasmNucleus

VIAS BIOLÓGICAS (3)
O-linked glycosylation of mucinsDefective GALNT3 causes HFTCDefective GALNT12 causes CRCS1
EXPRESSÃO TECIDUAL(Ubíquo)
Estômago
362.5 TPM
Pulmão
151.2 TPM
Rim - Medula
141.9 TPM
Rim - Córtex
95.1 TPM
Esôfago - Mucosa
82.9 TPM
OUTRAS DOENÇAS (1)
tubulointerstitial kidney disease, autosomal dominant, 2
HGNC:7508UniProt:P15941
UMODUromodulinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Functions in biogenesis and organization of the apical membrane of epithelial cells of the thick ascending limb of Henle's loop (TALH), where it promotes formation of complex filamentous gel-like structure that may play a role in the water barrier permeability (Probable). May serve as a receptor for binding and endocytosis of cytokines (IL-1, IL-2) and TNF (PubMed:3498215). Facilitates neutrophil migration across renal epithelia (PubMed:20798515) In the urine, may contribute to colloid osmotic p

LOCALIZAÇÃO

Apical cell membraneBasolateral cell membraneCell projection, cilium membraneSecreted

VIAS BIOLÓGICAS (1)
Asparagine N-linked glycosylation
MECANISMO DE DOENÇA

Tubulointerstitial kidney disease, autosomal dominant 1

A form of autosomal dominant tubulointerstitial kidney disease, a genetically heterogeneous disorder characterized by slowly progressive loss of kidney function, bland urinary sediment, hyperuricemia, absent or mildly increased albuminuria, lack of severe hypertension during the early stages, and normal or small kidneys on ultrasound. Renal histology shows variable abnormalities including interstitial fibrosis with tubular atrophy, microcystic dilatation of the tubules, thickening of tubular basement membranes, medullary cysts, and secondary glomerulosclerotic or glomerulocystic changes with abnormal glomerular tufting. There is significant variability, as well as incomplete penetrance.

EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Medula
2116.0 TPM
Rim - Córtex
190.5 TPM
Pâncreas
2.5 TPM
Testículo
0.9 TPM
Estômago
0.2 TPM
OUTRAS DOENÇAS (1)
familial juvenile hyperuricemic nephropathy type 1
HGNC:12559UniProt:P07911

Medicamentos aprovados (FDA)

1 medicamento encontrado nos registros da FDA americana.

💊 Jynarque (TOLVAPTAN)
Ver no DailyMed/FDA

Variantes genéticas (ClinVar)

206 variantes patogênicas registradas no ClinVar.

🧬 UMOD: NM_003361.4(UMOD):c.532C>G (p.Arg178Gly) ()
🧬 UMOD: NM_003361.4(UMOD):c.336C>G (p.Cys112Trp) ()
🧬 UMOD: NM_003361.4(UMOD):c.496G>T (p.Asp166Tyr) ()
🧬 UMOD: GRCh38/hg38 16p13.11-12.1(chr16:15368750-28342902)x4 ()
🧬 UMOD: NM_003361.4(UMOD):c.1676A>G (p.Tyr559Cys) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Doença renal túbulo-intersticial autossômica dominante

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

💬Melhor nível de evidência: Opinião
Timeline de publicações
181 papers (10 anos)
#1

Mutations in UMOD Contribute to the Pathogenesis of ADTKD-UMOD by Influencing the Function of Complement Factor H.

Journal of cellular and molecular medicine2026 Jan

Tubular atrophy and interstitial fibrosis are basic renal pathological changes in autosomal dominant tubulointerstitial kidney disease (ADTKD). Reduced secretion or abnormal structure of uromodulin (UMOD) are recognised pathogenic factors of ADTKD. Studies show uromodulin binds complement factor H (cFH), enhancing its ability to inhibit complement activation. Overactivation of the complement system contributes to tubulointerstitial injury. Therefore, exploring the UMOD-tubulointerstitial fibrosis link may aid in the development of treatment for ADTKD-UMOD. Immunofluorescence staining detected complement deposition in patients' kidneys. Uromodulin's binding affinity for cFH was assessed using microthermophoresis. The effect of this binding on cFH function was analysed using C3b degradation and erythrocyte hemolysis tests. Recombinant wild-type and mutant uromodulin proteins were expressed and tested using the aforementioned methods. Complement factor B was detected in the kidneys of patients with ADTKD-UMOD. Patient-derived uromodulin showed reduced binding to cFH and decreased capacity to assist in C3b cleavage and hemolysis inhibition. Recombinant wild-type uromodulin significantly enhanced C3b cleavage (p < 0.001) and inhibited hemolysis (p < 0.01). Uromodulin mutants showed reduced binding to cFH and limited ability to promote C3b degradation, with no significant hemolysis inhibition. Impaired interactions between mutants and cFH may lead to insufficient inhibition of complement activity, triggering tubulointerstitial fibrosis.

#2

MANF Clears Mutant Uromodulin in Human Kidney Organoids of Autosomal Dominant Tubulointerstitial Kidney Disease.

bioRxiv : the preprint server for biology2026 Mar 02

Autosomal dominant tubulointerstitial kidney disease due to uromodulin mutations (ADTKD-UMOD) is one of the leading hereditary kidney diseases. Currently there is no targeted treatment. To illuminate human relevance of mesencephalic astrocyte-derived neurotrophic factor (MANF)-based therapy, we have established patient induced pluripotent stem cell (iPSC)-derived kidney organoid model carrying UMOD p.H177-R185del, the leading mutation causing ADTKD. We have discovered that MANF can directly bind and repress ER calcium release channel IP3R1, thus enhancing AMPK-induced autophagy in a TRIB3-dependent manner. The therapeutic implication of this finding may well be extended to other protein misfolding diseases.

#3

De novo SEC61A1 mutation in congenital anemia and early-onset kidney disease: Case report and review of the literature.

Gene2026 Mar 16

Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a rare genetic disorder characterized by tubular damage and interstitial fibrosis, with inescapable progression to end-stage renal disease. SEC61A1-related ADTKD has long been neglected and underrecognized because of its rarity, insidious onset and variable clinical manifestations. A 13-year-old boy was referred to the pediatric nephrology clinic due to renal insufficiency, which had been found unexpectedly while visiting the hospital because of growth retardation. He had normocytic normochromic anemia since early childhood and was recently found to have agranulocytosis. The evaluation suggested elevated serum creatinine, hyperuricemia, bland urinary sediment, the absence of proteinuria, and renal cysts. A novel de novo heterozygous missense variant in SEC61A1, Ser71Pro, was found. So far fifteen patients with SEC61A1-related ADTKD have been reported, most of whom presented with early-onset chronic kidney disease and hyperuricemia. The extrarenal features included growth retardation, hematological abnormalities, cognitive impairment, and immunological abnormalities. There is no specific treatment for the SEC61A1-related ADTKD. Most reported patients survived to adulthood with supportive treatment. This is the first case of SEC61A1-related ADTKD of Chinese origin, extending its phenotype and mutation spectrum. The diagnosis of SEC61A1-related ADTKD should be considered in patients with early-onset or familial chronic kidney disease, hematological abnormalities and growth retardation, and mutation analysis of SEC61A1 is needed.

#4

A Partial UMOD Deletion Results in Altered Uromodulin Synthesis and Autosomal-Dominant Tubulointerstitial Kidney Disease-Uromodulin.

Kidney medicine2026 Apr

Autosomal dominant tubulointerstitial kidney disease-uromodulin (ADTKD-UMOD) is classically due to missense variants in UMOD that display a dominant-negative effect. Here, we describe a family with high clinical suspicion for ADTKD-UMOD for which no molecular diagnosis was obtained through standard techniques including extensive panel sequencing. Whole genome and long-read sequencing in multiple affected family members uncovered a large deletion (1,313 bp) encompassing part of exon 3, the entire intron 3 and exon 4, and part of intron 4, conserved regions of UMOD in which most known pathogenic variants are found. The pathogenic effect of the variant was validated through multimodal analysis of the urinary protein composition. Instead of loss of function, our data suggest that this deletion may result in an altered protein. This is the first large deletion demonstrated by functional assessment as responsible for ADTKD-UMOD, and importantly, it was undetected by conventional variant calling on short-read exome sequencing. Our results suggest that copy number variants may also be responsible for ADTKD-UMOD. We propose that when ADTKD is suspected but not explained by massive parallel sequencing and MUC1 analysis, additional sequencing techniques might unravel other types of genetic alteration, notably copy number variants, and thereby address unsolved ADTKD cases.

#5

Plasma Metabolites Associated with CKD Stage in Autosomal Dominant Tubulointerstitial Kidney Disease.

Kidney3602026 Feb 01

This is the first large-scale metabolomic study in genetically confirmed autosomal dominant tubulointerstitial kidney disease (ADTKD), providing a new resource for rare kidney diseases. ADTKD-UMOD and ADTKD-MUC1 are metabolically indistinguishable across stages, supporting the development of unified monitoring strategies. The plasma kynurenine-to-tryptophan ratio increases with CKD progression, supporting its use as a noninvasive marker of inflammation in ADTKD. Metabolomic profiling has not yet been performed in autosomal dominant tubulointerstitial kidney disease (ADTKD) due to UMOD or MUC1 mutations and could provide valuable insights into the pathophysiology of these conditions and identify the biomarkers of disease activity. Untargeted metabolomic analysis of plasma samples was performed on a cohort comprising 40 controls, 51 individuals with ADTKD-UMOD, and 49 individuals with ADTKD-MUC1 with CKD stages ranging from 1 to 4. Principal component analysis and hierarchical clustering revealed that the metabolic profiles of controls and ADTKD-UMOD and ADTKD-MUC1 patients with CKD stages 1 and 2 were similar. The metabolome was also similar between patients with ADTKD-UMOD and ADTKD-MUC1 at each stage of CKD. Compared with stage 2 CKD, stage 3 CKD was characterized by an increased kynurenine-to-tryptophan ratio, indicating activation of indoleamine 2,3-dioxygenase, an inflammation-induced and rate-limiting enzyme of tryptophan metabolism, and increased levels of pseudouridine, 3-indoxylsulfate, N-formylmethione, N-acetylated amino acids, acylcarnitines, and several other metabolites. In total, 121 metabolites were identified as significantly altered in patients in stage 4 compared with controls. Enrichment analysis of this set revealed that the most significant alterations were in the biosynthesis of arginine and branched-chain amino acids, carnitine synthesis, transfer RNA metabolism, tryptophan catabolism, urea cycle, metabolism of amino acids, glucose homeostasis, and solute carrier-mediated transmembrane transport. Patients with ADTKD-UMOD and ADTKD-MUC1 had similar metabolomic profiles across CKD stages. Although ADTKD is a tubulointerstitial kidney disease rather than glomerular, the effects on the metabolomic pathways appear comparable with those of other forms of CKD. The kynurenine-to-tryptophan ratio appears to be a promising biomarker of ADTKD progression and will require additional study.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC90 artigos no totalmostrando 168

2026

MANF Clears Mutant Uromodulin in Human Kidney Organoids of Autosomal Dominant Tubulointerstitial Kidney Disease.

bioRxiv : the preprint server for biology
2026

De novo SEC61A1 mutation in congenital anemia and early-onset kidney disease: Case report and review of the literature.

Gene
2026

A Partial UMOD Deletion Results in Altered Uromodulin Synthesis and Autosomal-Dominant Tubulointerstitial Kidney Disease-Uromodulin.

Kidney medicine
2026

Plasma Metabolites Associated with CKD Stage in Autosomal Dominant Tubulointerstitial Kidney Disease.

Kidney360
2026

Early-onset kidney failure in a girl with autosomal dominant tubulointerstitial kidney disease due to a de novo UMOD variant.

CEN case reports
2025

Hyperuricemia and elevated creatinine in a child with anemia.

The Turkish journal of pediatrics
2026

Calorie Restriction Leads to Degradation of Mutant Uromodulin and Ameliorates Inflammation and Fibrosis in UMOD -Related Kidney Disease.

Journal of the American Society of Nephrology : JASN
2026

JAG1 of all trades, master of CKD? The role of JAG1 in autosomal dominant tubulointerstitial kidney disease.

Kidney international
2026

Mutations in UMOD Contribute to the Pathogenesis of ADTKD-UMOD by Influencing the Function of Complement Factor H.

Journal of cellular and molecular medicine
2025

Case Report: UMOD gene mutation and phenotypic overlap with REN in autosomal dominant tubulointerstitial kidney disease.

Frontiers in genetics
2025

The diagnostic value of uromodulin protein measurement in autosomal dominant tubulointerstitial kidney disease due to uromodulin mutation (ADTKD-UMOD): serum or urine?

BMC nephrology
2026

Emerging Mechanistic Roles of STING Signaling in Kidney Diseases.

The American journal of pathology
2025

Renaming Medullary Cystic Kidney Disease: A Review of Semantic Nomenclature.

Cureus
2025

Targeted sequencing and iterative assembly of near-complete genomes.

Nature communications
2026

An unusual presentation of UMOD-associated autosomal dominant tubulointerstitial kidney disease in a pediatric patient.

Pediatric nephrology (Berlin, Germany)
2025

Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) in Chinese Patients.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2026

Mono-allelic pathogenic variants in JAG1 cause autosomal dominant tubulo-interstitial kidney disease (ADTKD-JAG1).

Kidney international
2025

An Observational Study of SGLT2 Inhibitors and Their Use in Autosomal Dominant Tubulointerstitial Kidney Disease.

Research square
2025

Long-Read Sequencing of the MUC1 VNTR: Genomic Variation, Mutational Landscape, and Its Impact on ADTKD Diagnosis and Progression.

bioRxiv : the preprint server for biology
2025

Autosomal Dominant Tubulointerstitial Kidney Disease: A Review.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2025

Genetic analysis of UMOD gene mutation in autosomal dominant tubulointerstitial kidney disease.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
2025

Autosomal dominant tubulointerstitial kidney disease-UMOD: a short review.

Orphanet journal of rare diseases
2025

Quantifying clinical and genetic factors influencing rate and severity of autosomal dominant tubulointerstitial kidney disease progression.

Journal of pharmacokinetics and pharmacodynamics
2026

Initial Suspicion of Autosomal Dominant Polycystic Kidney Disease Resulted in a Diagnosis of Autosomal Dominant Tubulointerstitial Kidney Disease Caused by a UMOD Mutation.

Internal medicine (Tokyo, Japan)
2025

Phenotypes and the Importance of Genetic Analysis in Adult Patients with Nephrolithiasis and/or Nephrocalcinosis: A Single-Center Experience.

Genes
2025

Characterization of recurrent UMOD variants (p.C255Y y p.Q316P) in a Galician cohort: genotype-phenotype correlation and clinical implications.

Nefrologia
2025

Clinical use of the VNtyper-Kestrel pipeline for MUC1 variant detection in autosomal-dominant tubulointerstitial kidney disease.

Clinical and experimental nephrology
2025

The spectrum of diseases, genetic landscape and new mutation sites of hereditary cystic kidney disease.

Clinical kidney journal
2025

Proteomic analysis of urinary extracellular vesicles from patients with ADTKD-HNF1β identifies roles for cilia-related proteins and serpins.

American journal of physiology. Renal physiology
2025

Endoplasmic reticulum stress as a driver and therapeutic target for kidney disease.

Nature reviews. Nephrology
2025

Phenotype and genotype of autosomal dominant tubulointerstitial kidney disease in a Japanese cohort.

Clinical and experimental nephrology
2025

Phenotypic Heterogeneity of ADTKD-MUC1 Diagnosed Using VNtyper, a Novel Genetic Technique.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2025

A Novel Heterozygous and Pathogenic Variant of the HNF1B Gene Associated with Autosomal Dominant Tubulointerstitial Kidney Disease with a Broad Spectrum of Extrarenal Phenotypes.

Internal medicine (Tokyo, Japan)
2025

Genetic Assessment of Living Kidney Transplant Donors: A Survey of Canadian Practices.

Canadian journal of kidney health and disease
2025

MUC1-associated autosomal dominant tubulointerstitial kidney disease: prevalence in kidney failure of undetermined aetiology and clinical insights from Danish families.

Clinical kidney journal
2024

Case Report: A potentially pathogenic new variant of the REN gene found in a family experiencing autosomal dominant tubulointerstitial kidney disease.

Frontiers in pediatrics
2024

Eight-fold increased COVID-19 mortality in autosomal dominant tubulointerstitial kidney disease due to MUC1 mutations: an observational study.

BMC nephrology
2024

Disrupted uromodulin trafficking is rescued by targeting TMED cargo receptors.

The Journal of clinical investigation
2025

Systematic Screening of Autosomal Dominant Tubulointerstitial Kidney Disease- MUC1 27dupC Pathogenic Variant through Exome Sequencing.

Journal of the American Society of Nephrology : JASN
2024

Familial juvenile hyperuricemic nephropathy: Revisiting the SLC8A1 gene, in a family with a novel terminal gross deletion in the UMOD gene.

Nefrologia
2024

A Rare Case of Atypical Hemolytic Uremic Syndrome Presenting as Chronic Interstitial Nephritis.

Cureus
2024

Advances in uromodulin biology and potential clinical applications.

Nature reviews. Nephrology
2024

Hypoaldosteronism due to a novel SEC61A1 variant successfully treated with fludrocortisone.

Clinical kidney journal
2024

A Novel Monoallelic ALG5 Variant Causing Late-Onset ADPKD and Tubulointerstitial Fibrosis.

Kidney international reports
2025

Autosomal-dominant tubulointerstitial kidney disease with a novel UMOD mutation, overlapping with Sjogren's syndrome: a case report.

CEN case reports
2024

Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2024

Genomic Testing in Patients with Kidney Failure of an Unknown Cause: A National Australian Study.

Clinical journal of the American Society of Nephrology : CJASN
2024

Genetic Diagnosis of Adult Hemodialysis Patients With Unknown Etiology.

Kidney international reports
2024

From Rare Disorders of Kidney Tubules to Acute Renal Injury: Progress and Prospective.

Kidney diseases (Basel, Switzerland)
2024

Description of a New Simple and Cost-Effective Molecular Testing That Could Simplify MUC1 Variant Detection.

Kidney international reports
2024

Case-inspired exploration of renin mutations in autosomal dominant tubulointerstitial kidney disease: not all paths lead to the endoplasmic reticulum.

Pediatric nephrology (Berlin, Germany)
2024

The Pathophysiology of Inherited Renal Cystic Diseases.

Genes
2024

Autosomal dominant ApoA4 mutations present as tubulointerstitial kidney disease with medullary amyloidosis.

Kidney international
2023

Autosomic Dominant Tubulo Interstitial Kidney Disease: Case Report of a New Variant of the UMOD Gene.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
2023

Allelic effects on uromodulin aggregates drive autosomal dominant tubulointerstitial kidney disease.

EMBO molecular medicine
2023

Atypical ADPKD Due to a DNAJB11 Pathogenic Variant: An Educational Case Report.

Canadian journal of kidney health and disease
2023

MANF stimulates autophagy and restores mitochondrial homeostasis to treat autosomal dominant tubulointerstitial kidney disease in mice.

Nature communications
2023

Maternal health and pregnancy outcomes in autosomal dominant tubulointerstitial kidney disease.

Obstetric medicine
2023

UMOD-related autosomal dominant tubulointerstitial kidney disease: an unfavourable novel mutation.

Nefrologia
2023

VNtyper enables accurate alignment-free genotyping of MUC1 coding VNTR using short-read sequencing data in autosomal dominant tubulointerstitial kidney disease.

iScience
2023

Dnajb11-Kidney Disease Develops from Reduced Polycystin-1 Dosage but not Unfolded Protein Response in Mice.

Journal of the American Society of Nephrology : JASN
2023

Hypoxia controls expression of kidney-pathogenic MUC1 variants.

Life science alliance
2023

Leader peptide or pro-segment mutants of renin are misrouted to mitochondria in autosomal dominant tubulointerstitial kidney disease.

Disease models &amp; mechanisms
2023

Genomics in the kidney clinic.

Clinical medicine (London, England)
2023

Cystic Diseases of the Kidneys: From Bench to Bedside.

Indian journal of nephrology
2023

Corrigendum to "Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease"Kidney International Reports, Volume 7, Issue 4, April 2022, Pages 857-866.

Kidney international reports
2023

Novel MUC1 variant identified by massively parallel sequencing explains interstitial kidney disease in a large Dutch family.

Kidney international
2023

MANF stimulates autophagy and restores mitochondrial homeostasis to treat toxic proteinopathy.

bioRxiv : the preprint server for biology
2023

Influence of glycoprotein MUC1 on trafficking of the Ca2+-selective ion channels, TRPV5 and TRPV6, and on in vivo calcium homeostasis.

The Journal of biological chemistry
2023

Genetic Susceptibility to Chronic Kidney Disease: Links, Risks and Management.

International journal of nephrology and renovascular disease
2022

ADTKD-UMOD in a girl with a de novo mutation: A case report.

Frontiers in medicine
2022

UMOD and you! Explaining a rare disease diagnosis.

Journal of rare diseases (Berlin, Germany)
2023

Transcription factor HNF1β controls a transcriptional network regulating kidney cell structure and tight junction integrity.

American journal of physiology. Renal physiology
2022

Autosomal Dominant Tubulointerstitial Kidney Disease: An Emerging Cause of Genetic CKD.

Kidney international reports
2022

Altered Serum Uric Acid Levels in Kidney Disorders.

Life (Basel, Switzerland)
2022

Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Journal of clinical medicine
2022

Hypertensive Emergency In UMOD-Related Autosomal Dominant Tubulointerstitial Kidney Disease.

The Brown journal of hospital medicine
2022

UMOD Mutations in Chronic Kidney Disease in Taiwan.

Biomedicines
2022

Framework From a Multidisciplinary Approach for Transitioning Variants of Unknown Significance From Clinical Genetic Testing in Kidney Disease to a Definitive Classification.

Kidney international reports
2022

An intermediate-effect size variant in UMOD confers risk for chronic kidney disease.

Proceedings of the National Academy of Sciences of the United States of America
2022

Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis.

American journal of human genetics
2023

Kidney Histology Findings in a Patient with Autosomal Dominant Tubulointerstitial Kidney Disease Subtype Hepatocyte Nuclear Factor 1β.

Internal medicine (Tokyo, Japan)
2022

Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases.

Kidney international
2022

Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease.

Kidney international reports
2022

Alport syndrome and autosomal dominant tubulointerstitial kidney disease frequently underlie end-stage renal disease of unknown origin-a single-center analysis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2022

Upregulation of C/EBP Homologous Protein induced by ER Stress Mediates Epithelial to Myofibroblast Transformation in ADTKD-UMOD.

International journal of medical sciences
2022

Phenylbutyrate rescues the transport defect of the Sec61α mutations V67G and T185A for renin.

Life science alliance
2021

Autosomal dominant tubulointerstitial kidney disease with a novel heterozygous missense mutation in the uromodulin gene: A case report.

World journal of clinical cases
2022

What is the cause of kidney dysfunction in a newborn with trisomy 21? Answers.

Pediatric nephrology (Berlin, Germany)
2023

Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2022

Family History is Important to Identify Patients with Monogenic Causes of Adult-Onset Chronic Kidney Disease.

Nephron
2022

The causes and consequences of paediatric kidney disease on adult nephrology care.

Pediatric nephrology (Berlin, Germany)
2021

Ultrabright plasmonic fluor nanolabel-enabled detection of a urinary ER stress biomarker in autosomal dominant tubulointerstitial kidney disease.

American journal of physiology. Renal physiology
2021

Ultra-rare renal diseases diagnosed with whole-exome sequencing: Utility in diagnosis and management.

BMC medical genomics
2021

Plasma Mucin-1 (CA15-3) Levels in Autosomal Dominant Tubulointerstitial Kidney Disease due to MUC1 Mutations.

American journal of nephrology
2022

Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β.

Pediatric nephrology (Berlin, Germany)
2021

Autosomal Dominant Tubulointerstitial Kidney Disease HNF1B With Maturity-Onset Diabetes of the Young: A Case Report With Kidney Biopsy.

Kidney medicine
2021

Familial juvenile hyperuricemia in early childhood in a boy with a novel gene mutation.

CEN case reports
2021

Autosomal dominant tubulointerstitial kidney disease genotype and phenotype correlation in a Chinese cohort.

Scientific reports
2021

Uromodulin: Roles in Health and Disease.

Annual review of physiology
2022

Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2021

Significance of kidney biopsy in autosomal dominant tubulointerstitial kidney disease-UMOD: is kidney biopsy truly nonspecific?

BMC nephrology
2021

A Rare Kidney Disease To Cure Them All? Towards Mechanism-Based Therapies for Proteinopathies.

Trends in molecular medicine
2020

The Varied Clinical Presentation of Autosomal Dominant Tubulointerstitial Kidney Disease Due to HNF1β Mutations.

Kidney international reports
2020

Variable Expressivity of HNF1B Nephropathy, From Renal Cysts and Diabetes to Medullary Sponge Kidney Through Tubulo-interstitial Kidney Disease.

Kidney international reports
2020

Clinical and genetic spectra of kidney disease caused by REN mutations.

Kidney international
2021

Bi-allelic pathogenic variations in DNAJB11 cause Ivemark II syndrome, a renal-hepatic-pancreatic dysplasia.

Kidney international
2021

A woman with a dual genetic diagnosis of autosomal dominant tubulointerstitial kidney disease and KBG syndrome.

CEN case reports
2020

Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations.

Kidney international reports
2020

A novel likely pathogenic variant in the UMOD gene in a family with autosomal dominant tubulointerstitial kidney disease: a case report.

BMC nephrology
2020

[Patients with a kidney disease can benefit from a specific genetic diagnose].

Ugeskrift for laeger
2020

Autosomal dominant tubulointerstitial kidney disease: a new tool to guide genetic testing.

Kidney international
2020

A novel HNF1B mutation p.R177Q in autosomal dominant tubulointerstitial kidney disease and maturity-onset diabetes of the young type 5: A pedigree-based case report.

Medicine
2020

An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes.

Kidney international
2020

SMRT sequencing revealed to be an effective method for ADTKD-MUC1 diagnosis through follow-up analysis of a Chinese family.

Scientific reports
2020

Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1.

Kidney international
2020

Hypomagnesemia is underestimated in children with HNF1B mutations.

Pediatric nephrology (Berlin, Germany)
2020

Exome Sequencing and Identification of Phenocopies in Patients With Clinically Presumed Hereditary Nephropathies.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2020

Autosomal Dominant Tubulointerstitial Kidney Disease-Uromodulin Misclassified as Focal Segmental Glomerulosclerosis or Hereditary Glomerular Disease.

Kidney international reports
2020

Role of transcription factor hepatocyte nuclear factor-1β in polycystic kidney disease.

Cellular signalling
2020

Renal transplant outcomes in patients with autosomal dominant tubulointerstitial kidney disease.

Clinical transplantation
2020

Homoplasmy of the Mitochondrial DNA Mutation m.616T>C Leads to Mitochondrial Tubulointerstitial Kidney Disease and Encephalopathia.

Nephron
2019

Quality of life in patients with autosomal dominant tubulointerstitial kidney disease
.

Clinical nephrology
2019

A novel disease-causing mutation in the Renin gene in a Tunisian family with autosomal dominant tubulointerstitial kidney disease.

The international journal of biochemistry &amp; cell biology
2019

Autosomal dominant tubulointerstitial kidney disease (ADTKD) in Ireland.

Renal failure
2019

Autosomal dominant tubulointerstitial kidney disease.

Nature reviews. Disease primers
2019

Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutation: A Two-Case Report and Literature Review.

Nephron
2019

Autosomal Dominant Tubulointerstitial Kidney Disease with Adult Onset due to a Novel Renin Mutation Mapping in the Mature Protein.

Scientific reports
2019

Discovery of a Novel Mutation in the REN Gene in Patient With Chronic Progressive Kidney Disease of Unknown Etiology Presenting With Acute Spontaneous Carotid Artery Dissection.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
2020

Outcomes of patient self-referral for the diagnosis of several rare inherited kidney diseases.

Genetics in medicine : official journal of the American College of Medical Genetics
2019

Diagnosis and Long-term Management of Uromodulin Kidney Disease.

Cureus
2019

UMOD gene mutations in Chinese patients with autosomal dominant tubulointerstitial kidney disease: a pediatric case report and literature review.

BMC pediatrics
2019

Uromodulin-related autosomal-dominant tubulointerstitial kidney disease-pathogenetic insights based on a case.

Clinical kidney journal
2018

Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease.

BMC nephrology
2018

Mucin-1 Gene Mutation and the Kidney: The Link between Autosomal Dominant Tubulointerstitial Kidney Disease and Focal and Segmental Glomerulosclerosis.

Case reports in nephrology
2019

Endoplasmic reticulum stress and monogenic kidney diseases in precision nephrology.

Pediatric nephrology (Berlin, Germany)
2018

Mechanism of Fibrosis in HNF1B-Related Autosomal Dominant Tubulointerstitial Kidney Disease.

Journal of the American Society of Nephrology : JASN
2018

Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition.

Journal of the American Society of Nephrology : JASN
2018

Noninvasive Immunohistochemical Diagnosis and Novel MUC1 Mutations Causing Autosomal Dominant Tubulointerstitial Kidney Disease.

Journal of the American Society of Nephrology : JASN
2018

Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2018

A novel uromodulin mutation in autosomal dominant tubulointerstitial kidney disease: a pedigree-based study and literature review.

Renal failure
2018

Transcription factor HNF1β regulates expression of the calcium-sensing receptor in the thick ascending limb of the kidney.

American journal of physiology. Renal physiology
2018

Single molecule real time sequencing in ADTKD-MUC1 allows complete assembly of the VNTR and exact positioning of causative mutations.

Scientific reports
2018

Identification of a novel UMOD mutation (c.163G>A) in a Brazilian family with autosomal dominant tubulointerstitial kidney disease.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
2018

Autosomal Tubulointerstitial Kidney Disease-MUC1 Type: Differential Proteomics Suggests that Mutated MUC1 (insC) Affects Vesicular Transport in Renal Epithelial Cells.

Proteomics
2019

A novel UMOD gene mutation associated with chronic kidney failure at a young age.

Clinical nephrology
2018

Autosomal Dominant Tubulointerstitial Kidney Disease Due to MUC1 Mutation.

American journal of kidney diseases : the official journal of the National Kidney Foundation
2017

Elevated urinary CRELD2 is associated with endoplasmic reticulum stress-mediated kidney disease.

JCI insight
2018

The UMOD Locus: Insights into the Pathogenesis and Prognosis of Kidney Disease.

Journal of the American Society of Nephrology : JASN
2017

Analysis of an ADTKD family with a novel frameshift mutation in MUC1 reveals characteristic features of mutant MUC1 protein.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2017

Early involvement of cellular stress and inflammatory signals in the pathogenesis of tubulointerstitial kidney disease due to UMOD mutations.

Scientific reports
2017

Uromodulin: from physiology to rare and complex kidney disorders.

Nature reviews. Nephrology
2017

Discovery of a novel dominant mutation in the REN gene after forty years of renal disease: a case report.

BMC nephrology
2017

A review on autosomal dominant tubulointerstitial kidney disease.

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia
2017

A novel homozygous UMOD mutation reveals gene dosage effects on uromodulin processing and urinary excretion.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
2017

Loss of transcriptional activation of the potassium channel Kir5.1 by HNF1β drives autosomal dominant tubulointerstitial kidney disease.

Kidney international
2017

Mutant uromodulin expression leads to altered homeostasis of the endoplasmic reticulum and activates the unfolded protein response.

PloS one
2017

A mouse model for inherited renal fibrosis associated with endoplasmic reticulum stress.

Disease models &amp; mechanisms
2017

Mitochondrial Dysregulation Secondary to Endoplasmic Reticulum Stress in Autosomal Dominant Tubulointerstitial Kidney Disease - UMOD (ADTKD-UMOD).

Scientific reports
2016

Mucin-1 Increases Renal TRPV5 Activity In Vitro, and Urinary Level Associates with Calcium Nephrolithiasis in Patients.

Journal of the American Society of Nephrology : JASN
2017

A new missense mutation in UMOD gene leads to severely reduced serum uromodulin concentrations - A tool for the diagnosis of uromodulin-associated kidney disease.

Clinical biochemistry
2016

Development and characterization of a pseudo multiple reaction monitoring method for the quantification of human uromodulin in urine.

Bioanalysis
2016

Development and Validation of a Mass Spectrometry-Based Assay for the Molecular Diagnosis of Mucin-1 Kidney Disease.

The Journal of molecular diagnostics : JMD
2016

Testing for the cytosine insertion in the VNTR of the MUC1 gene in a cohort of Italian patients with autosomal dominant tubulointerstitial kidney disease.

Journal of nephrology
2016

From juvenile hyperuricaemia to dysfunctional uromodulin: an ongoing metamorphosis.

Pediatric nephrology (Berlin, Germany)
2016

Autosomal dominant tubulointerstitial kidney disease caused by uromodulin mutations: seek and you will find.

Wiener klinische Wochenschrift
2015

Hypomagnesemia as First Clinical Manifestation of ADTKD-HNF1B: A Case Series and Literature Review.

American journal of nephrology
2015

Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--A KDIGO consensus report.

Kidney international

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Doença renal túbulo-intersticial autossômica dominante.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Doença renal túbulo-intersticial autossômica dominante

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Mutations in UMOD Contribute to the Pathogenesis of ADTKD-UMOD by Influencing the Function of Complement Factor H.
    Journal of cellular and molecular medicine· 2026· PMID 41531277mais citado
  2. MANF Clears Mutant Uromodulin in Human Kidney Organoids of Autosomal Dominant Tubulointerstitial Kidney Disease.
    bioRxiv : the preprint server for biology· 2026· PMID 41867867mais citado
  3. De novo SEC61A1 mutation in congenital anemia and early-onset kidney disease: Case report and review of the literature.
    Gene· 2026· PMID 41850665mais citado
  4. A Partial UMOD Deletion Results in Altered Uromodulin Synthesis and Autosomal-Dominant Tubulointerstitial Kidney Disease-Uromodulin.
    Kidney medicine· 2026· PMID 41798828mais citado
  5. Plasma Metabolites Associated with CKD Stage in Autosomal Dominant Tubulointerstitial Kidney Disease.
    Kidney360· 2026· PMID 41746789mais citado
  6. Single-Molecule Real-Time Sequencing for MUC1 VNTR Variation to Improve Autosomal Dominant Tubulointerstitial Kidney Disease Diagnosis.
    J Am Soc Nephrol· 2026· PMID 41961547recente
  7. A novel and two recurrent UMOD mutations in autosomal dominant tubulointerstitial kidney disease (ADTKD): a case series and literature review.
    Ren Fail· 2026· PMID 41958050recente
  8. Lipocalin-2 Is Induced by Uromodulin Aggregates without Impacting Kidney Disease Progression in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD.
    J Am Soc Nephrol· 2026· PMID 41885939recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:34149(Orphanet)
  2. MONDO:0008264(MONDO)
  3. GARD:10801(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q1916694(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Doença renal túbulo-intersticial autossômica dominante
Compêndio · Raras BR

Doença renal túbulo-intersticial autossômica dominante

ORPHA:34149 · MONDO:0008264
CID-10
Q61.5 · Cisto medular do rim
CID-11
Início
Adolescent, Adult, Childhood, Infancy
MedGen
UMLS
C1859040
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades